Results 91 to 100 of about 5,403,298 (185)
Navigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine
ABSTRACT Glycogen synthase kinase‐3 (GSK‐3) is a central regulator of numerous cellular signaling pathways, with critical roles in metabolism, proliferation, differentiation, and tissue regeneration. This review explores the multifaceted effects of pharmacological GSK‐3 inhibition across multiple body districts, focusing on its highly context‐dependent
Davide Schiroli +5 more
wiley +1 more source
Predictive Power of EEG in Infants with Tuberous Sclerosis
Investigators from University of California- Los Angeles and collaborators from across the country report on the use of prospective EEGs in infants with tuberous sclerosis complex (TSC) to predict evolution to seizures.
Molly Tracy
doaj +1 more source
In vivo gene therapy with plasmid DNA-tuberous sclerosis complex-2 (TSC-2) in an oral squamous cell carcinoma. [PDF]
Supriatno - Terapi gen menggunakan plasmid DNA-Tuberous sclerosis complex-2 (TSC-2) pada sel skuamos karsinoma rongga mulut in vivo Latar belakang: Tuberous sclerosis complex (TSC), suatu sindrom bawaan yang mempengaruhi individu terhadap tingginya ...
Supriatmo
core +2 more sources
This review summarizes how natural products, mainly including flavonoids, terpenoids, alkaloids, and polyphenols alleviate RA via PI3K/Akt pathway, regulating inflammation, proliferation, apoptosis, angiogenesis, and osteoclast differentiation. The figure was created by Figdraw (https://www.figdraw.com/#/).
Haishuo Ren +10 more
wiley +1 more source
Oral lesions in tuberous sclerosis
Tuberous sclerosis complex (TSC) is an autosomal-dominant neurocutaneous syndrome with an approximate incidence of 1 in 10,000–50,000. The cardinal features of TSC are skin lesions, convulsive seizures, and mental retardation.
Lakshmi S Reddy +3 more
doaj +1 more source
Spatial multi‐omics mapping of hepatic angiomyolipoma reveals that PEComas tightly co‐localize with endothelial cells, which drive autophagic flux in adjacent tumor cells via a paracrine PDGFD–PDGFRB–Ras axis, establishing a compensatory survival network that operates in parallel to canonical TSC–mTOR defects.
Xinyang Liu +9 more
wiley +1 more source
Tuberous Sclerosis Complex Presenting as Periungual Fibromas: A Rare Case Report and Literature Review [PDF]
Ying Li,1,* Zhipeng Wang,1,* Yanhua Yang,2 Xiaoyan Xu3 1Department of Pathology, Sanya Central Hospital (The Third People’s Hospital of Hainan Province), Sanya, 572000, People’s Republic of China; 2Department of Pathology, Qingdao Municipal ...
Li Y, Yang Y, Xu X, Wang Z
core
David Neal Franz Department of Pediatrics, Tuberous Sclerosis Clinic, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA Abstract: Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder caused by inactivating ...
Franz DN
doaj
Tuberous sclerosis complex (TSC), first described in 1880, is a disorder that affects multiple systems. Its symptoms include seizures, intellectual disability, and angiofibromas.
Wame T. Chabalala +3 more
doaj +1 more source
Risk Factors for Autism in Tuberous Sclerosis
The prevalence and risk factors for autism spectrum disorders (ASD) in a cohort of 103 patients with tuberous sclerosis complex (TSC) were determined in a study at the Massachusetts General Hospital, Boston, MA.
J Gordon Millichap
doaj +1 more source

